NCT03186924 Reducing Sedentary Time in Rheumatoid Arthritis: The Take a STAND for Health Study Status UNKNOWN Phase NA
NCT03173040 The Efficacy of the Traditional Chinese Medicine Niubang Pill Combined With Methotrexate on Active Rheumatoid Arthritis Status UNKNOWN Phase PHASE2/PHASE3
NCT03170947 Effects of Insoles in Patients With Rheumatoid Arthritis: Randomized Controlled Trial. Status UNKNOWN Phase NA
NCT03161457 A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis Status TERMINATED Phase PHASE1
NCT03156023 Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT03155347 An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy Status COMPLETED Phase PHASE3
NCT03152396 Pharmacist CVD Intervention for Patients With Inflammatory Arthritis Status UNKNOWN Phase NA
NCT03149796 Tocilizumab Effect on microRNA Expression and Adipokine Levels in Rheumatoid Arthritis Patients Status COMPLETED Phase N/A
NCT03147248 A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA Status COMPLETED Phase PHASE3
NCT03142958 Clinical Evaluation of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement (CADENCE) Status SUSPENDED Phase N/A
NCT03139136 Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT03131973 Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin Status COMPLETED Phase PHASE1
NCT03120949 Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT03112213 Characterization of Non-Steroidal Anti-Inflammatory Drug (NSAID) Intake in Rheumatoid Arthritis (RA) Participants on Tocilizumab (RoACTEMRA®) Treatment Status COMPLETED Phase N/A
NCT03110094 Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis Status COMPLETED Phase NA
NCT03109470 The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience Status WITHDRAWN Phase N/A